Thioridazine Hydrochloride

CHEMBL1200916 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
407.0 g/mol
LogP
Phase
4

A hydrochloride salt form of thioridazine with the same therapeutic properties. This older antipsychotic medication was used to treat schizophrenia and severe behavioral problems, but its use is now very restricted due to serious risks including irreversible damage to the retina of the eye and potentially fatal heart rhythm abnormalities.

Peso molecular

407,0000 g/mol

TPSA

57,10 Ų

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2.Cl

InChI

InChI=1S/C21H26N2S2.ClH/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23;/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3;1H

Molecular Formula

C21H27ClN2S2

HBD / HBA

1 / 4

Enlaces Rotables

4

Átomos Pesados

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A hydrochloride salt form of thioridazine with the same therapeutic properties. This older antipsychotic medication was used to treat schizophrenia and severe behavioral problems, but its use is now very restricted due to serious risks including irreversible damage to the retina of the eye and potentially fatal heart rhythm abnormalities.

Yes, Thioridazine Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200916. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 66062. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.